1. Home
  2. TRVI vs MTUS Comparison

TRVI vs MTUS Comparison

Compare TRVI & MTUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • MTUS
  • Stock Information
  • Founded
  • TRVI 2011
  • MTUS 1899
  • Country
  • TRVI United States
  • MTUS United States
  • Employees
  • TRVI N/A
  • MTUS 1880
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • MTUS
  • Sector
  • TRVI Health Care
  • MTUS
  • Exchange
  • TRVI Nasdaq
  • MTUS NYSE
  • Market Cap
  • TRVI 629.8M
  • MTUS 546.3M
  • IPO Year
  • TRVI 2019
  • MTUS N/A
  • Fundamental
  • Price
  • TRVI $5.83
  • MTUS $13.43
  • Analyst Decision
  • TRVI Strong Buy
  • MTUS
  • Analyst Count
  • TRVI 8
  • MTUS 0
  • Target Price
  • TRVI $19.31
  • MTUS N/A
  • AVG Volume (30 Days)
  • TRVI 1.0M
  • MTUS 431.7K
  • Earning Date
  • TRVI 05-08-2025
  • MTUS 05-08-2025
  • Dividend Yield
  • TRVI N/A
  • MTUS N/A
  • EPS Growth
  • TRVI N/A
  • MTUS N/A
  • EPS
  • TRVI N/A
  • MTUS N/A
  • Revenue
  • TRVI N/A
  • MTUS $1,042,900,000.00
  • Revenue This Year
  • TRVI N/A
  • MTUS $8.67
  • Revenue Next Year
  • TRVI N/A
  • MTUS $9.17
  • P/E Ratio
  • TRVI N/A
  • MTUS N/A
  • Revenue Growth
  • TRVI N/A
  • MTUS N/A
  • 52 Week Low
  • TRVI $2.30
  • MTUS $10.78
  • 52 Week High
  • TRVI $7.39
  • MTUS $24.28
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 56.14
  • MTUS 52.45
  • Support Level
  • TRVI $6.08
  • MTUS $12.34
  • Resistance Level
  • TRVI $6.47
  • MTUS $13.39
  • Average True Range (ATR)
  • TRVI 0.39
  • MTUS 0.45
  • MACD
  • TRVI -0.00
  • MTUS 0.00
  • Stochastic Oscillator
  • TRVI 45.06
  • MTUS 64.53

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About MTUS METALLUS INC

Metallus Inc is an America-based manufacturer of alloy steel, as well as carbon and micro-alloy steel. The portfolio of the company includes special bar quality steel, seamless mechanical tubes, and value-add solutions, such as precision steel components. The company also supplies machining and thermal treatment services and manages raw material recycling programs that work as a feeder system for its melt operations. The company's products and services are used in the following sectors: oil and gas; automotive; industrial equipment; mining; construction; rail; aerospace and defense; heavy truck; agriculture and power generation. Geographically, the company mainly serves customers in the United States.

Share on Social Networks: